ES8301634A1 - Procedimiento de obtencion de vacuna contra la tosferiana. - Google Patents

Procedimiento de obtencion de vacuna contra la tosferiana.

Info

Publication number
ES8301634A1
ES8301634A1 ES504740A ES504740A ES8301634A1 ES 8301634 A1 ES8301634 A1 ES 8301634A1 ES 504740 A ES504740 A ES 504740A ES 504740 A ES504740 A ES 504740A ES 8301634 A1 ES8301634 A1 ES 8301634A1
Authority
ES
Spain
Prior art keywords
translation
procedure
machine
legally binding
google translate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES504740A
Other languages
English (en)
Other versions
ES504740A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmachim DSO
Original Assignee
Pharmachim DSO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmachim DSO filed Critical Pharmachim DSO
Priority to ES504740A priority Critical patent/ES504740A0/es
Publication of ES8301634A1 publication Critical patent/ES8301634A1/es
Publication of ES504740A0 publication Critical patent/ES504740A0/es
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA OBTENER UNA VACUNA DE ADMINISTRACION ORAL, CONTRA LA TOSFERINA. SE CULTIVAN BACTERIAS DE TOSFERINA VIVA, DE LA CEPA BORDETELLA EM 1964, EN UM MEDIO BORGET-GENOU, DURANTE 48 HORAS Y A 37<025>C, CON LO CUAL SE LOGRA LA ASOCIACION DE LA CITADA BACTERIA DE TOSFERINA VIVA A UN AGENTE TRANSMISOR, FARMACOLOGICAMENTE ACEPTABLE. LA SUSPENSION OBTENIDA ANTERIORMENTE SE DISUELVE EN UNA SOLUCION SALINA FISIOLOGICA Y DILUIDA EN ELLA, PARA SU ADMINISTRACION. LAS CANTIDADES DE DILUCION SON DE 3 MILLONES A 3 MIL MILLONES DE ORGANISMOS MICROBIANOS POR 1 ML DE SAL FISIOLOGICA CONTENIDOS EN CADA UNIDAD DE DOSIFICACION.
ES504740A 1981-08-13 1981-08-13 Procedimiento de obtencion de vacuna contra la tosferiana. Granted ES504740A0 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES504740A ES504740A0 (es) 1981-08-13 1981-08-13 Procedimiento de obtencion de vacuna contra la tosferiana.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES504740A ES504740A0 (es) 1981-08-13 1981-08-13 Procedimiento de obtencion de vacuna contra la tosferiana.

Publications (2)

Publication Number Publication Date
ES8301634A1 true ES8301634A1 (es) 1983-01-01
ES504740A0 ES504740A0 (es) 1983-01-01

Family

ID=8482844

Family Applications (1)

Application Number Title Priority Date Filing Date
ES504740A Granted ES504740A0 (es) 1981-08-13 1981-08-13 Procedimiento de obtencion de vacuna contra la tosferiana.

Country Status (1)

Country Link
ES (1) ES504740A0 (es)

Also Published As

Publication number Publication date
ES504740A0 (es) 1983-01-01

Similar Documents

Publication Publication Date Title
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
KR940005636A (ko) 트리아졸릴티오메틸티오 세팔로스포린 염산염, 그의 수화물 결정 및 이들의 제조방법
ES8704170A1 (es) Un procedimiento para preparar derivados de guanina
ATE83659T1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
NO870241D0 (no) Hypoglykemiske tiazolidindioner.
SE8402549L (sv) Substituerade moranolinderivat
FR2670491B1 (fr) Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant.
NO178858C (no) Analogifremgangsmåte for fremstilling av substituerte 4-fenyl-4-piperidinkarboksamider med både lokal anestetisk og analgetisk effekt
ES510245A0 (es) &#34;un metodo para obtener una preparacion de insulina&#34;.
SE8602743L (sv) Bruksferdiga injektionslosningar innehallande en antitumorantracyklinglykosid
MY113803A (en) Fluorophenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as medicament or diagnostic, and medicament containing them.
MX157054A (es) Procedimiento para preparar derivados de disenzoxazepina
KR890006621A (ko) 항불안제
NO861096L (no) Nye 5-fluorbenzonitril-derivater, anvendelse derav, dyreforblanding og fremgangsmaate for fremstilling derav.
NO840526L (no) Derivater av n-iminopyridiniumbetainer, fremgangsmaate til deres fremstilling og deres anvendelse i medikamenter
SU1469826A1 (ru) Сополимер l-лизина с l-глутаминовой кислотой, содержащий дофаминовые боковые группы, обладающий пролонгированной гипотензивной активностью и компенсаторным эффектом при геморрагическом шоке, и способ его получения
IT1226072B (it) Soluzioni iniettabili pronte all&#39;uso contenenti un glicoside antraciclinico antitumorale.
ES8600758A1 (es) Procedimiento para preparar derivados de1,3-dioxolanilo
GB1421308A (en) Physiological saline solution
RU96104214A (ru) Способ лечения транссудативных форм центральных хориоретинальных дистрофий
DE3262732D1 (en) Anthranilic acids substituted by basic groups, process for their preparation and their use
ATE126437T1 (de) Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf.
FR2413383A1 (fr) Derives de type 5,6-dihydro-prostacycline, leurs procedes de preparation et leurs applications therapeutiques
SE8106498L (sv) Kvaternera salter av n,n3-di(beta-brompropionyl)-n1,n2-dispirotripiperazinium, forfarande for framstellning av desamma och lekemedelspreparat innehallande desamma
Veyssier et al. Concentrations of moxalactam in ventricular CSF during the treatment of a Klebsiella pneumoniae.